ArticleScientific reports2026
Biocontrol potential of endophytic Sphingobium xenophagum J-1 against Fusarium oxysporum causing root rot in Paris polyphylla var. yunnanensis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Paris polyphylla var. yunnanensis (PPY) is a valuable medicinal plant frequently threatened by root rot caused by pathogenic fungi such as Fusarium oxysporum. Traditional chemical control methods pose environmental and resistance risks, highlighting the need for sustainable alternatives. This study investigated the antifungal potential of the endophytic bacterium Sphingobium xenophagum J-1, isolated from healthy PPY, against F. oxysporum in vitro. The ethyl acetate crude extract of J-1 fermentation broth exhibited significant concentration-dependent inhibition of spore germination, with a 94.64% inhibition rate at 12.5 mg/mL. Microscopic and physiological analyses revealed that the extract severely damaged fungal hyphae, causing swelling, fragmentation, cytoplasmic leakage, and intracellular cavitation. Furthermore, the extract appeared to disrupt cell membrane integrity. These findings suggest that J-1 may act through inhibition of spore germination, hyphal degradation, and membrane disruption. This study provides preliminary in vitro evidence that S. xenophagum J-1 exhibits antifungal activity against F. oxysporum. These findings suggest that strain J-1 represents a promising candidate with in vitro antifungal potential, although its biocontrol efficacy in planta remains to be validated through greenhouse and field experiments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.